Newron Pharmaceuticals
NWRN.SW
#8592
Rank
โ‚น11.73 B
Marketcap
โ‚น610.36
Share price
-5.96%
Change (1 day)
-19.03%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -โ‚น92.52

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น92.52. In 2023 the company made an earnings per share (EPS) of -โ‚น92.52 a decrease over its 2022 EPS that were of -โ‚น90.68.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-โ‚น92.522.03%
2022-โ‚น90.6815.39%
2021-โ‚น78.59-31.32%
2020-โ‚น114.4214.74%
2019-โ‚น99.7236.6%
2018-โ‚น73.00159.87%
2017-โ‚น28.09-67.81%
2016-โ‚น87.27-39.24%
2015-โ‚น143.62107.61%
2014-โ‚น69.1815.8%
2013-โ‚น59.74119.91%
2012-โ‚น27.16-66.51%
2011-โ‚น81.10-71.49%
2010-โ‚น284.48-10.83%
2009-โ‚น319.0542.06%
2008-โ‚น224.5956.53%
2007-โ‚น143.48-52.84%
2006-โ‚น304.24-188.53%
2005โ‚น343.67